Cape Verde vs Zimbabwe: Access to anti-retroviral drugs, female
Cape Verde
98.0%
in 2024
Zimbabwe
98.0%
in 2024
Cape Verde rank
1st
Zimbabwe rank
1st
Access to anti-retroviral drugs, female over time
- Cape Verde
- Zimbabwe
How they compare
Cape Verde currently reports 98.0% against 98.0% in Zimbabwe, a difference of 0.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Zimbabwe ahead.
Cape Verde ranks 1st and Zimbabwe ranks 1st of 141 countries.
Across the 3 decades both report, Cape Verde averaged higher in 2 and Zimbabwe in 1.
Head to head by decade
| Decade | Cape Verde | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.9% | 4.3% | 5.6% | Cape Verde |
| 2010s | 59.5% | 63.8% | 4.3% | Zimbabwe |
| 2020s | 96.6% | 96.0% | 0.6% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Cape Verde or Zimbabwe?
- Cape Verde, at 98.0% against 98.0% in Zimbabwe as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Cape Verde and Zimbabwe?
- 0.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Zimbabwe?
- 25 years are reported by both, from 2000 to 2024.
- How do Cape Verde and Zimbabwe rank globally for access to anti-retroviral drugs, female?
- Cape Verde ranks 1st and Zimbabwe ranks 1st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.